NL9100960A - Dichlooranilineverbinding. - Google Patents

Dichlooranilineverbinding. Download PDF

Info

Publication number
NL9100960A
NL9100960A NL9100960A NL9100960A NL9100960A NL 9100960 A NL9100960 A NL 9100960A NL 9100960 A NL9100960 A NL 9100960A NL 9100960 A NL9100960 A NL 9100960A NL 9100960 A NL9100960 A NL 9100960A
Authority
NL
Netherlands
Prior art keywords
compound
formula
solution
amino
methanol
Prior art date
Application number
NL9100960A
Other languages
English (en)
Dutch (nl)
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB909012465A external-priority patent/GB9012465D0/en
Priority claimed from GB919104645A external-priority patent/GB9104645D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of NL9100960A publication Critical patent/NL9100960A/nl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30Oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NL9100960A 1990-06-05 1991-06-04 Dichlooranilineverbinding. NL9100960A (nl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB909012465A GB9012465D0 (en) 1990-06-05 1990-06-05 Chemical compounds
GB9012465 1990-06-05
GB919104645A GB9104645D0 (en) 1991-03-05 1991-03-05 Chemical compound
GB9104645 1991-03-05

Publications (1)

Publication Number Publication Date
NL9100960A true NL9100960A (nl) 1992-01-02

Family

ID=26297165

Family Applications (1)

Application Number Title Priority Date Filing Date
NL9100960A NL9100960A (nl) 1990-06-05 1991-06-04 Dichlooranilineverbinding.

Country Status (25)

Country Link
EP (1) EP0460924A1 (US07122547-20061017-C00273.png)
JP (1) JPH05117236A (US07122547-20061017-C00273.png)
KR (1) KR920000717A (US07122547-20061017-C00273.png)
AP (1) AP251A (US07122547-20061017-C00273.png)
AT (1) AT399874B (US07122547-20061017-C00273.png)
AU (1) AU635424B2 (US07122547-20061017-C00273.png)
BE (1) BE1005612A5 (US07122547-20061017-C00273.png)
CA (1) CA2043850A1 (US07122547-20061017-C00273.png)
CH (1) CH682322A5 (US07122547-20061017-C00273.png)
DE (1) DE4118293A1 (US07122547-20061017-C00273.png)
DK (1) DK106991A (US07122547-20061017-C00273.png)
ES (1) ES2036920B1 (US07122547-20061017-C00273.png)
FI (1) FI912679A (US07122547-20061017-C00273.png)
FR (1) FR2662691A1 (US07122547-20061017-C00273.png)
GB (1) GB2244709B (US07122547-20061017-C00273.png)
GR (1) GR1001309B (US07122547-20061017-C00273.png)
IE (1) IE911898A1 (US07122547-20061017-C00273.png)
IL (1) IL98363A0 (US07122547-20061017-C00273.png)
IT (1) IT1245868B (US07122547-20061017-C00273.png)
LU (1) LU87945A1 (US07122547-20061017-C00273.png)
MY (1) MY106672A (US07122547-20061017-C00273.png)
NL (1) NL9100960A (US07122547-20061017-C00273.png)
OA (1) OA09501A (US07122547-20061017-C00273.png)
PT (1) PT97858A (US07122547-20061017-C00273.png)
SE (1) SE500706C2 (US07122547-20061017-C00273.png)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9104650D0 (en) * 1991-03-05 1991-04-17 Glaxo Group Ltd Medicaments
ZA994264B (en) 1998-07-01 2000-01-25 Warner Lambert Co Stereoisomers with high affinity for adrenergic receptors.
US7232837B2 (en) 1999-06-29 2007-06-19 Mcneil-Ppc, Inc. Stereoisomers with high affinity for adrenergic receptors
GB0014546D0 (en) 2000-06-14 2000-08-09 Glaxo Group Ltd A novel process
FR2960153B1 (fr) * 2010-05-20 2012-08-17 Centre Nat Rech Scient Nouveaux bras autoreactifs et prodrogues les comprenant

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1618005A1 (de) * 1966-09-22 1971-09-09 Thomae Gmbh Dr K Verfahren zur Herstellung von neuen Amino-dihalogen-phenyl-aethylaminen
EP0021636B1 (en) * 1979-06-16 1982-12-01 Beecham Group Plc Secondary amines, their preparation and use in pharmaceutical compositions
GB8426191D0 (en) * 1984-10-17 1984-11-21 Glaxo Holdings Ltd Chemical compounds
GB8603475D0 (en) * 1986-02-12 1986-03-19 Glaxo Group Ltd Chemical compounds
ES8802416A1 (es) * 1986-04-15 1988-06-01 Glaxo Group Ltd Un procedimiento para la preparacion de derivados de dicloroanilina.

Also Published As

Publication number Publication date
IE911898A1 (en) 1991-12-18
GR910100242A (en) 1992-08-25
EP0460924A1 (en) 1991-12-11
GB9111946D0 (en) 1991-07-24
LU87945A1 (fr) 1993-01-15
FR2662691A1 (fr) 1991-12-06
AP9100271A0 (en) 1991-07-31
AT399874B (de) 1995-08-25
IL98363A0 (en) 1992-07-15
ES2036920B1 (es) 1994-02-16
JPH05117236A (ja) 1993-05-14
FI912679A (fi) 1991-12-06
ES2036920A1 (es) 1993-06-01
OA09501A (en) 1992-11-15
ITRM910387A1 (it) 1992-12-04
FI912679A0 (fi) 1991-06-04
KR920000717A (ko) 1992-01-29
BE1005612A5 (fr) 1993-11-23
GB2244709B (en) 1994-02-09
DK106991D0 (da) 1991-06-04
SE9101687L (sv) 1991-12-06
AU7812791A (en) 1991-12-12
SE9101687D0 (sv) 1991-06-04
DE4118293A1 (de) 1991-12-12
IT1245868B (it) 1994-10-25
FR2662691B1 (US07122547-20061017-C00273.png) 1994-04-22
ATA112891A (de) 1994-12-15
SE500706C2 (sv) 1994-08-15
GB2244709A (en) 1991-12-11
MY106672A (en) 1995-07-31
AP251A (en) 1993-04-20
GR1001309B (el) 1993-08-31
CA2043850A1 (en) 1991-12-06
AU635424B2 (en) 1993-03-18
DK106991A (da) 1991-12-06
PT97858A (pt) 1992-03-31
ITRM910387A0 (it) 1991-06-04
CH682322A5 (US07122547-20061017-C00273.png) 1993-08-31

Similar Documents

Publication Publication Date Title
FR2545482A1 (fr) Derives de phenethanolamine
KR100250922B1 (ko) 교감신경 흥분 및 항빈뇨 활성을 갖는 에탄올아민 유도체
WO1993018007A1 (en) Novel carbostyril derivative
FR2596049A1 (fr) Derives de dichloroaniline
US5621142A (en) Aminoalkylcyclopropane derivatives
KR100192622B1 (ko) 페네타놀아민 화합물
EP1214313B1 (fr) Heteroaryloxypropanolamines comme agonistes du recepteur beta3-adrenergique
EP0443498A1 (en) Isoindoline derivatives
EP1960387B1 (fr) Derives de isoquinoline et benzo[h]isoquinoline, leur preparation et leur utilisation en therapeutique en tant qu antagonistes du recepteur de l histamine h3
US5252578A (en) 3-aminochroman compounds
NL9100960A (nl) Dichlooranilineverbinding.
US6136852A (en) 3,4-disubstituted phenylethanolaminotetralincarboxylic acid derivatives
EP0322263B1 (fr) Carbamates tricycliques, leur procédé de préparation et leur application en thérapeutique
EP0467435A2 (en) Benzhydryl derivatives having calmodulin inhibitor properties
BE897000A (fr) Nouveaux derives de la 1,4-dihydropyridine,leur preparation et leur utilisation comme medicaments
US4198419A (en) Phenylthiophenylpiperidines
WO1998041497A1 (fr) Derives de propanolamine
EP0139921B1 (en) 2-phenylethylamine derivatives
EP0520882B1 (fr) Dérivés de 2-aminopyrimidine-4-carboxamide, leur préparation et leur application en thérapeutique
KR20100046256A (ko) 치료 조성물
US4999351A (en) 7-aryl and heteroaryl ethers of desacetylforskolin
FR2663026A1 (fr) Derives de [(1-arylpyrrolidin-2-yl) methyl] piperazine, leur preparation et leur application en therapeutique.
US5177207A (en) 7-aryl and heteroaryl ethers of desacetylforskolin
WO1999009001A1 (fr) Derives de phenylethanolaminotetraline et bronchodilatateurs
BE569697A (US07122547-20061017-C00273.png)

Legal Events

Date Code Title Description
BV The patent application has lapsed